Literature DB >> 27006116

Complement-mediated 'bystander' damage initiates host NLRP3 inflammasome activation.

Rahul Suresh1, Prabha Chandrasekaran1, Fayyaz S Sutterwala2, David M Mosser3.   

Abstract

Complement activation has long been associated with inflammation, primarily due to the elaboration of the complement anaphylotoxins C5a and C3a. In this work, we demonstrate that the phagocytosis of complement-opsonized particles promotes host inflammatory responses by a new mechanism that depends on the terminal complement components (C5b-C9). We demonstrate that during the phagocytosis of complement-opsonized particles, the membrane attack complex (MAC) of complement can be transferred from the activating particle to the macrophage plasma membrane by a 'bystander' mechanism. This MAC-mediated bystander damage initiates NLRP3 inflammasome activation, resulting in caspase-1 activation and IL-1β and IL-18 secretion. Inflammasome activation is not induced when macrophages phagocytize unopsonized particles or particles opsonized with serum deficient in one of the terminal complement components. The secretion of IL-1β and IL-18 by macrophages depends on NLRP3, ASC (also known as PYCARD) and caspase-1, as macrophages deficient in any one of these components fail to secrete these cytokines following phagocytosis. The phagocytosis of complement-opsonized particles increases leukocyte recruitment and promotes T helper 17 cell (TH17) biasing. These findings reveal a new mechanism by which complement promotes inflammation and regulates innate and adaptive immunity.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  ASC; Bystander activation; Caspase; Complement; IL-18; IL-1β; Inflammasome; Membrane attack complex; NLRP3; Phagocytosis; TH17

Mesh:

Substances:

Year:  2016        PMID: 27006116      PMCID: PMC4893798          DOI: 10.1242/jcs.179291

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  65 in total

Review 1.  Effects of the membrane attack complex of complement on nucleated cells.

Authors:  B P Morgan
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

Review 3.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

4.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

5.  Neoantigens of the membrane attack complex of human complement.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

6.  Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration.

Authors:  K Lueck; S Wasmuth; J Williams; T R Hughes; B P Morgan; A Lommatzsch; J Greenwood; S E Moss; D Pauleikhoff
Journal:  Eye (Lond)       Date:  2011-05-20       Impact factor: 3.775

7.  Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Silvana Martino; Luca Vergano; Inna Lastauka; Arrigo Schieppati; Marina Noris; Pier Angelo Tovo; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2014-08-31       Impact factor: 3.714

8.  Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection.

Authors:  Ricardo Goncalves; Xia Zhang; Heather Cohen; Alain Debrabant; David M Mosser
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.

Authors:  Melissa J Mulla; Jane E Salmon; Larry W Chamley; Jan J Brosens; Crina M Boeras; Paula B Kavathas; Vikki M Abrahams
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.

Authors:  Esin Güven; Karen Duus; Inga Laursen; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  23 in total

1.  Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.

Authors:  Anna M Blom; Michal Magda; Lisa Kohl; Jutamas Shaughnessy; John D Lambris; Sanjay Ram; David Ermert
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

2.  TNF-α/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis.

Authors:  Yixin Liu; Wei Wei; Yang Wang; Chunyou Wan; Yingyu Bai; Xuguo Sun; Jun Ma; Fang Zheng
Journal:  Inflamm Res       Date:  2019-05-22       Impact factor: 4.575

Review 3.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

4.  NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.

Authors:  Sheng-Tao Yao; Fang Cao; Jia-Lin Chen; Wei Chen; Rui-Ming Fan; Gang Li; You-Chao Zeng; Song Jiao; Xiang-Ping Xia; Chong Han; Qi-Shan Ran
Journal:  J Mol Neurosci       Date:  2016-12-08       Impact factor: 3.444

Review 5.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

Review 6.  Complement in Kidney Transplantation.

Authors:  Marek Cernoch; Ondrej Viklicky
Journal:  Front Med (Lausanne)       Date:  2017-05-30

7.  In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.

Authors:  Nawal Bahia El Idrissi; Anand M Iyer; Valeria Ramaglia; Patricia S Rosa; Cleverson T Soares; Frank Baas; Pranab K Das
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

8.  The role of complement activation in rhabdomyolysis-induced acute kidney injury.

Authors:  XuDong Huang; Wei Zhao; LiXia Zhang; XinJun Yang; LiHui Wang; YunShuang Chen; JingHua Wang; Chao Zhang; GuangLi Wu
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

Review 9.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

10.  SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Andrzej Ciechanowicz; Kasia Sielatycka; Monika Cymer; Wojciech Marlicz; Magda Kucia
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.